Vaccine News and Research

Latest Vaccine News and Research

WHO welcomes G8 endorsement of the Global HIV Vaccine Enterprise

The World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) today welcomed the G8's endorsement of the Global HIV Vaccine Enterprise, a virtual consortium proposed by an international group of scientists that is being established to accelerate HIV vaccine development.

11 Jun 2004

U.S.$2.8 to study a virus associated with respiratory infections

The Center for Emerging Infectious Diseases (CEID), based in the University of Iowa College of Public Health, has been awarded a five-year, $2.8 million grant by the National Institute of Allergy and Infectious Diseases to study a virus associated with respiratory infections.

11 Jun 2004

U.S. team to battle malaria in Peru

In the middle of the Peruvian Amazon, a battle against malaria – the second largest killer of people worldwide – will be undertaken by an international team of researchers led by tropical disease specialist Joseph Vinetz, M.D., from the University of California, San Diego (UCSD) School of Medicine.

11 Jun 2004

Postnatal exposure to a mercury preservative commonly used in a number of childhood vaccines can lead to the development of autism-like damage

A new study published online June 8 in the Nature publication, Molecular Psychiatry, indicates that postnatal exposure to thimerosal, a mercury preservative commonly used in a number of childhood vaccines, can lead to the development of autism-like damage in autoimmune disease susceptible mice

11 Jun 2004

Australian government to provide free pneumococcal disease vaccinations

The Commonwealth Government will provide free vaccines to protect newborn babies and older people from pneumococcal disease, as well as a catch up program for toddlers.

11 Jun 2004

Prostate cancer immunotherapy vaccine hits clinical trials

Scientists at the Austrlia's, Queensland Institute of Medical Research (QIMR) are currently trialing an experimental "immunotherapy" treatment for men with advanced prostate cancer.

10 Jun 2004

HIV infection impairs immunity to malaria in pregnant women

"Scientists from the University of Melbourne, Australia, the United States and Malawi studying infections with malaria and HIV, have found a strong link between the two diseases, which affect millions of people around the world and are major scourges in sub-Saharan Africa.

7 Jun 2004

Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma

Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.

7 Jun 2004

150 top scientists debate and offer expert advice on cutting edge vaccine research

More than 150 top scientists, researchers and public health experts from around the world will meet in Switzerland next week to present, debate and offer expert advice on cutting edge vaccine research and development, as well as vaccine policy and implementation.

3 Jun 2004

Latest version of the Approved List of Biological Agents published

The Advisory Committee on Dangerous Pathogens (ACDP) today published the latest version of the Approved List of Biological Agents.('The Approved List').

3 Jun 2004

Reliability of medical research in Britain today questioned by the general public

Doctors, patients and the general public depend on results of scientific research to provide information about the safety and effectiveness of medical treatments. Following the controversy surrounding the Andrew Wakefield study on the link between MMR vaccines and autism, the public is now considering the reliability of medical research in Britain today.

2 Jun 2004

Tuberculosis test kits order

Medical Services International Inc.has announced that it has received its first order for the VScan Tuberculosis (TB) rapid test kit from a prominent pharmaceutical company that produces Tuberculosis vaccines.

2 Jun 2004

New medical patent covering the generation of genetically enhanced therapeutic antigens

Morphotek, Inc. announced today the issuance of United States Patent 6,737,268 covering the generation of genetically enhanced therapeutic antigens.

2 Jun 2004

Malaria, Africa's biggest killer

It's Africa's biggest killer, but it's not HIV. It causes economic losses of US$12 billion per year, but it's not a war. And it has slowed African economic growth by around 1.3 per cent per annum, but it’s not a famine.

2 Jun 2004

Double-punch approach to vaccine design more effective

A study revealing new information about how viral proteins move between cells and alert the immune system suggests that a double-punch approach to vaccine design would make them more effective.

1 Jun 2004

Bird flu vaccine

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded two contracts to support the production and clinical testing of an investigational vaccine based on a strain of avian influenza, H5N1, which might have the potential to cause pandemic influenza.

27 May 2004

Blueprint for rational design of vaccines that induce desired T-cell responses

Investigators from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have conducted studies in mice to gain a new picture of how the immune system’s “killer” T cells are prompted to destroy infected cells. Their insights provide a blueprint for rational design of vaccines that induce desired T-cell responses.

27 May 2004

Link between oral bacterium and premature babies

For years, scientists have noticed a particular oral bacterium can be found in the amniotic fluid of about 20 percent of women with premature babies.

27 May 2004

Research tests the efficacy of a smallpox vaccine candidate known as LC16m8

When used as an aerosolized weapon, smallpox could be controlled by a new vaccine under study at Saint Louis University School of Medicine, according to new data.

27 May 2004

Wyeth to seek rehearing of court ruling

Wyeth today said it would seek rehearing of a decision issued by the United States Court of Appeals for the Third Circuit reversing rulings by U.S. District Court Judge Harvey Bartle III of the Eastern District of Pennsylvania which excluded certain evidence in state court diet drug trials.

25 May 2004